Pneumagen to Present Phase 2 Clinical Data on Neumifil, its Broad-Spectrum Antiviral, Intranasal Drug for Viral Respiratory Tract Infections, at ATS 2024
02 mai 2024 07h00 HE
|
Pneumagen Ltd
Data to be presented in oral and ePoster presentations St Andrews, UK – 2 May 2024 - Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for...
PharmaTher’s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine
01 mai 2024 08h00 HE
|
PharmaTher Holdings Ltd.
TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announced today Sairiyo...
Infectious Disease Connect Expands Telemedicine Services
16 avr. 2024 09h15 HE
|
Infectious Disease Connect
PITTSBURGH, April 16, 2024 (GLOBE NEWSWIRE) -- Infectious Disease Connect (ID Connect), a leading infectious diseases telemedicine and software solutions company, has expanded its services to meet...
Exosomes Market revenue to hit USD 5.3 Billion by 2036, says Research Nester
08 janv. 2024 05h30 HE
|
Research Nester
New York, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The global exosomes market size is slated to expand at ~16% CAGR between 2024 and 2036. The market is poised to garner a revenue of USD 5.3 billion by the...
Chemiluminescence Immunoassay Analyzers Market Size Worth USD 9.7 Billion in 2032 | Emergen Research
18 déc. 2023 06h54 HE
|
Emergen Research
Vancouver, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The global Chemiluminescence Immunoassay (CLIA) analyzers market size was USD 5.42 Billion in 2022 and is expected to register rapid revenue CAGR of 6.0%...
Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
12 déc. 2023 02h00 HE
|
Icosavax, Inc.
Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
20Med Therapeutics Appoints Industry Veteran Hugo Fry as Chief Business Officer to Expedite mRNA Vaccine Delivery Platform Program
29 nov. 2023 03h00 HE
|
20MED Therapeutics B.V.
Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the appointment of Hugo Fry as Chief Business Officer. His appointment...
Novotech Publishes Whitepaper on Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials Launched Worldwide
06 nov. 2023 19h10 HE
|
Novotech
Novotech CRO today published the latest 2023 global clinical trial environment whitepaper focused on infectious diseases.
Global In-Vitro Diagnostics Market Size is Projected to Reach USD 116.32 Billion by 2030, with a CAGR of 5.2%: Straits Research
31 oct. 2023 14h50 HE
|
Straits Research
New York, United States, Oct. 31, 2023 (GLOBE NEWSWIRE) -- In-vitro diagnostics, or IVD, are medical devices and reagents used to examine body fluids and tissues to diagnose diseases, conditions,...
Scinai Reports Third Quarter 2023 Financial Results and Provides Business Update
31 oct. 2023 08h23 HE
|
Scinai Immunotherapeutics Ltd.
JERUSALEM, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- Scinai Immunotherapeutics Ltd (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative...